Items where authors include "Del Galdo, F."
Up a levelArticle
Avanoglu-Guler, A. orcid.org/0000-0001-9866-9797, Campochiaro, C., De Luca, G. et al. (6 more authors) (2024) Calcinosis in systemic sclerosis: An update on pathogenesis, related complications, and management: A heavy burden still waiting to be lifted off patients’ hands. Seminars in Arthritis and Rheumatism, 66. 152431. ISSN 0049-0172
De Lorenzis, E. orcid.org/0000-0001-9819-105X, Mor, A., Ross, R.L. et al. (4 more authors) (2024) Serum CCL24 as a biomarker of fibrotic and vascular disease severity in Systemic Sclerosis. Arthritis Care & Research. ISSN 2151-464X
Suresh, N. orcid.org/0000-0001-7431-3921, Karanth, R., Cheah, R. et al. (3 more authors) (2024) Systemic sclerosis and anorectal dysfunction: The Leeds experience. Journal of Scleroderma and Related Disorders. ISSN 2397-1983
Wasson, C.W., De Lorenzis, E., Clavane, E.M. et al. (14 more authors) (2024) The Beta secretase BACE1 drives fibroblasts activation in Systemic Sclerosis through the APP/β-catenin/Notch signalling axis. Journal of Investigative Dermatology. ISSN 0022-202X
Álvarez-Hernández, M.P. orcid.org/0000-0002-9972-1312, Allanore, Y., Andrade, I. et al. (9 more authors) (2024) Attitudes and barriers to pulmonary arterial hypertension screening in systemic sclerosis patients: A survey of UK-based rheumatologists. Journal of Scleroderma and Related Disorders. ISSN 2397-1983
Bandini, G. orcid.org/0000-0002-2076-7319, Alunno, A. orcid.org/0000-0003-1105-5640, Alcacer-Pitarch, B. orcid.org/0000-0002-2208-444X et al. (14 more authors) (2024) Patients’ unmet needs and treatment preferences concerning digital ulcers in systemic sclerosis. Rheumatology. keae130. ISSN 1462-0324
Tornling, G., Edenius, C., Pauling, J.D. et al. (16 more authors) (2024) A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's. Rheumatology. keae049. ISSN 1462-0324
De Lorenzis, E. orcid.org/0000-0001-9819-105X, Kakkar, V., Di Donato, S. et al. (13 more authors) (2024) Clinical trajectories of hand function impairment in systemic sclerosis: an unmet clinical need across disease subsets. RMD Open, 10 (1). e003216. ISSN 2056-5933
Liakouli, V. orcid.org/0000-0002-7392-9334, Ciancio, A., Del Galdo, F. orcid.org/0000-0002-8528-2283 et al. (2 more authors) (2024) Systemic sclerosis interstitial lung disease: unmet needs and potential solutions. Nature Reviews Rheumatology, 20 (1). pp. 21-32. ISSN 1759-4790
Lepri, G., Bruni, C. orcid.org/0000-0003-2813-2083, Tofani, L. orcid.org/0000-0001-9965-7667 et al. (23 more authors) (2024) The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis—Interstitial Lung Disease in the European Scleroderma Trial and Research Database. Diagnostics, 14 (3). ARTN 295. ISSN 2075-4418
Lescoat, A., Bellando-Randone, S., Campochiaro, C. et al. (9 more authors) (2023) Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine. The Lancet Rheumatology, 5 (11). e683-e694. ISSN 2665-9913
Di Battista, M. orcid.org/0000-0002-4788-5729, Wasson, C.W., Alcacer-Pitarch, B. orcid.org/0000-0002-2208-444X et al. (1 more author) (2023) Autonomic dysfunction in systemic sclerosis: A scoping review. Seminars in Arthritis and Rheumatism, 63. 152268. ISSN 0049-0172
Hughes, M. orcid.org/0000-0003-3361-4909, Di Donato, S. orcid.org/0000-0003-1256-0761, Gjeloshi, K. et al. (9 more authors) (2023) MRI Digital Artery Volume Index (DAVIX) as a surrogate outcome measure of digital ulcer disease in patients with systemic sclerosis: a prospective cohort study. The Lancet Rheumatology, 5 (10). e611-e621. ISSN 2665-9913
De Lorenzis, E., Rindone, A., Di Donato, S. et al. (1 more author) (2023) Circulating extracellular vesicles in the context of interstitial lung disease related to systemic sclerosis: A scoping literature review. Autoimmunity Reviews, 22 (9). 103401. ISSN 1568-9972
Griffiths-Jones, D.J., Garcia, Y.S., Ryder, W.D. et al. (19 more authors) (2023) A Phase II randomized controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS). Rheumatology, 62 (9). pp. 3133-3138. ISSN 1462-0324
Mills, T.J., Price, E., Aggarwal, V.R. orcid.org/0000-0003-0838-9682 et al. (2 more authors) (2023) Clinician and Patient Experiences of Managing and Living with Oral and Dental Manifestations of Scleroderma: A Scoping Review. Journal of Scleroderma and Related Disorders. ISSN 2397-1983
Colalillo, A., Pellicano, C., Ananyeva, L.P. et al. (12 more authors) (2023) Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio and Cardiorenal Syndrome Type 2 in the Systemic Sclerosis EUSTAR Cohort. Arthritis Care & Research. ISSN 2151-464X
Lescoat, A., Huang, S., Carreira, P.E. et al. (219 more authors) (2023) Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database. JAMA Dermatology, 159 (8). pp. 837-847. ISSN 2168-6068
Lepri, G., Hughes, M., Allanore, Y. et al. (8 more authors) (2023) The role of skin ultrasound in systemic sclerosis: looking below the surface to understand disease evolution. The Lancet Rheumatology, 5 (7). e422-e425. ISSN 2665-9913
De Lorenzis, E. orcid.org/0000-0001-9819-105X, Wasson, C.W. and Del Galdo, F. orcid.org/0000-0002-8528-2283 (2023) Alveolar epithelial-to-mesenchymal transition in scleroderma interstitial lung disease: Technical challenges, available evidence and therapeutic perspectives. Journal of Scleroderma and Related Disorders. ISSN 2397-1983
John, A.J.U.K. orcid.org/0000-0003-3080-7393, Del Galdo, F. orcid.org/0000-0002-8528-2283, Gush, R. orcid.org/0000-0002-8624-3606 et al. (1 more author) (2023) An evaluation of mechanical and biophysical skin parameters at different body locations. Skin Research and Technology, 29 (2). e13292. ISSN 0909-752X
Dumitru, R.B., Bissell, L., Erhayiem, B. et al. (8 more authors) (2023) Subclinical Systemic Sclerosis Primary Heart Involvement by Cardiovascular Magnetic Resonance Shows No Significant Interval Change. ACR Open Rheumatology, 5 (2). pp. 71-80. ISSN 2578-5745
Griffiths-Jones, D.J., Garcia, Y.S., Ryder, W.D. et al. (19 more authors) (2023) A Phase II randomized controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS). Rheumatology. ISSN 1462-0324
Bosello, S.L., Vital, E.M. orcid.org/0000-0003-1637-4755 and Del Galdo, F. orcid.org/0000-0002-8528-2283 (2022) More to B: the growing evidence to inform targeting B cells in scleroderma. Rheumatology, 62 (5). pp. 1730-1732. ISSN 1462-0324
Campochiaro, C. orcid.org/0000-0001-6806-3794, Hoffmann-Vold, A.-M. orcid.org/0000-0001-6467-7422, Avouac, J. et al. (90 more authors) (2022) Sex influence on outcomes of patients with systemic sclerosis–associated interstitial lung disease: a EUSTAR database analysis. Rheumatology, 62 (7). pp. 2483-2491. ISSN 1462-0324
Bellando-Randone, S., Del Galdo, F. orcid.org/0000-0002-8528-2283 and Matucci-Cerinic, M. (2022) Insights into molecular and clinical characteristics of very early systemic sclerosis. Current Opinion in Rheumatology, 34 (6). pp. 351-356. ISSN 1040-8711
Kakkar, V., Assassi, S., Allanore, Y. et al. (4 more authors) (2022) Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culprit. Current Opinion in Rheumatology, 34 (6). pp. 357-364. ISSN 1040-8711
Hughes, M., Allanore, Y., Baron, M. et al. (13 more authors) (2022) Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease. The Lancet Rheumatology, 4 (11). e795-e803. ISSN 2665-9913
Elhai, M., Sritharan, N., Boubaya, M. et al. (167 more authors) (2022) Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort. The Lancet Rheumatology, 4 (11). e785-e794. ISSN 2665-9913
Kondo, M., Suzuki, T., Kawano, Y. et al. (10 more authors) (2022) Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosis. Arthritis Research & Therapy, 24. 210. ISSN 0003-4967
Cipriani, P., Ruscitti, P., Di Cola, I. et al. (6 more authors) (2022) Fibroblast expression of CD248 may contribute to exacerbation of microvascular damage during systemic sclerosis. Rheumatology, 62 (3). pp. 1317-1325. ISSN 1462-0324
Zheng, B. orcid.org/0000-0003-2509-5766, Wang, M., McKenna, K. et al. (16 more authors) (2022) Agreement Between Physician Evaluation and the Composite Response Index in Diffuse Cutaneous Systemic Sclerosis. Arthritis Care & Research, 74 (11). pp. 1806-1812. ISSN 2151-464X
Lescoat, A., Murphy, S.L., Chen, Y.T. et al. (5 more authors) (2022) Symptom experience of limited cutaneous systemic sclerosis from the Patients’ perspective: A qualitative study. Seminars in Arthritis and Rheumatism, 52. 151926. ISSN 0049-0172
Kreuter, M. orcid.org/0000-0003-4402-2159, Del Galdo, F. orcid.org/0000-0002-8528-2283, Miede, C. et al. (7 more authors) (2022) Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis. Arthritis Research & Therapy, 24. 19. ISSN 1478-6354
Abignano, G. orcid.org/0000-0002-1479-0133, Hermes, H., Piera-Velazquez, S. et al. (3 more authors) (2021) Global gene expression analysis of systemic sclerosis myofibroblasts demonstrates a marked increase in the expression of multiple NBPF genes. Scientific Reports, 11. 20435. ISSN 2045-2322
Abignano, G. orcid.org/0000-0002-1479-0133, Mennillo, G.A., Lettieri, G. orcid.org/0000-0002-7422-554X et al. (6 more authors) (2021) UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract (GIT) 2.0 Reflux Scale Correlates With Impaired Esophageal Scintigraphy Findings in Systemic Sclerosis. The Journal of Rheumatology, 48 (9). pp. 1422-1426. ISSN 0315-162X
Di Battista, M., Barsotti, S., Orlandi, M. et al. (5 more authors) (2021) One year in review 2021: systemic sclerosis. Clinical and Experimental Rheumatology, 39 (4). S3-S12. ISSN 0392-856X
Antinozzi, C. orcid.org/0000-0003-4296-5081, Sgrò, P. orcid.org/0000-0003-4929-2764, Marampon, F. et al. (4 more authors) (2021) Sildenafil Counteracts the In Vitro Activation of CXCL-9, CXCL-10 and CXCL-11/CXCR3 Axis Induced by Reactive Oxygen Species in Scleroderma Fibroblasts. Biology, 10 (6). 491. ISSN 2079-7737
Corinaldesi, C., Ross, R.L., Abignano, G. orcid.org/0000-0002-1479-0133 et al. (8 more authors) (2021) Muscle Damage in Systemic Sclerosis and CXCL10: The Potential Therapeutic Role of PDE5 Inhibition. International Journal of Molecular Sciences, 22 (6). 2894. ISSN 1661-6596
Wasson, C., Ross, R., Wells, R. et al. (4 more authors) (2020) Long Non-coding RNA HOTAIR Induces GLI2 Expression Through Notch Signalling in Systemic Sclerosis Dermal Fibroblasts. Arthritis Research & Therapy, 22. 286. ISSN 1478-6354
Lescoat, A., Murphy, S.L., Roofeh, D. et al. (17 more authors) (2020) Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomes. Journal of Scleroderma and Related Disorders, 6 (1). 66 -76. ISSN 2397-1983
Abignano, G. orcid.org/0000-0002-1479-0133 and Del Galdo, F. orcid.org/0000-0002-8528-2283 (2020) Biomarkers as an opportunity to stratify for outcome in systemic sclerosis. European Journal of Rheumatology, 7 (Supplement 3). S193-S202. ISSN 2147-9720
Di Luigi, L., Duranti, G., Antonioni, A. et al. (9 more authors) (2020) The Phosphodiesterase Type 5 Inhibitor Sildenafil Improves DNA Stability and Redox Homeostasis in Systemic Sclerosis Fibroblasts Exposed to Reactive Oxygen Species. Antioxidants, 9 (9). 786. ISSN 2076-3921
Del Galdo, F. orcid.org/0000-0002-8528-2283, Hartley, C. and Allanore, Y. (2020) Randomised controlled trials in systemic sclerosis: patient selection and endpoints for next generation trials. The Lancet Rheumatology, 2 (3). e173-e184. ISSN 2665-9913
Conference or Workshop Item
Del Galdo, F. orcid.org/0000-0002-8528-2283, Tian, Y., Di Donato, S. et al. (1 more author) (2023) The Patient Journey to a First Diagnosis of Systemic Sclerosis: Temporal Disease Pattern Identification Using Machine Learning and Data Mining Among US and Japanese Patients. In: ACR Convergence 2023, 10-15 Nov 2023, San Diego, California.
Del Galdo, F. orcid.org/0000-0002-8528-2283, Khanna, D., Crater, C. et al. (6 more authors) (2023) AB0808 a proof of biological concept trial of CM101 to target CCL24 in systemic sclerosis: a biomarker informed, precision medicine approach. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.
De Lorenzis, E., Natalello, G., Di Donato, S. et al. (6 more authors) (2023) AB0841 concordance and prognostic relevance of different definitions of systemic sclerosis interstitial lung disease progression. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.
De Lorenzis, E., Kakkar, V., Di Donato, S. et al. (13 more authors) (2023) AB0881 clinical trajectories of multifactorial hand function deterioration in systemic sclerosis. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.
Ross, R., Clarke, E., Merchant, W. et al. (8 more authors) (2023) POS0146 biosamples from vedoss patients show classic pathological signs of scleroderma:opportunity for a biological diagnosis of disease. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.
Verardi, L., De Lorenzis, E., Pellegrino, G. et al. (19 more authors) (2023) POS1324 mycophenolate mofetil use in clinical practice in a multicentric cohort of scleroderma patients: persistence on therapy and long-term adverse events. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.
Stock, C., Kreuter, M., Del Galdo, F. orcid.org/0000-0002-8528-2283 et al. (7 more authors) (2021) PRS3 Joint Modelling of Forced Vital Capacity Decline and Time to Hospitalization Outcomes in Systemic Sclerosis-Associated Interstitial Lung Disease. In: Virtual ISPOR 2021, 17-20 May 2021, Online.
Temiz Karadağ, D., Gundogdu, O., Lettieri, G. et al. (5 more authors) (2020) AB0617 optical coherence tomography in the assessment of skin fibrosis in systemic sclerosis: a cross-sectional study. In: EULAR 2020 - Annual European Congress of Rheumatology, 03-06 Jun 2020, Virtual.
Abignano, G. orcid.org/0000-0002-1479-0133, Temiz Karadağ, D., Gundogdu, O. et al. (6 more authors) (2020) FRI0226 optical coherence tomography of the skin detects scleroderma changes in clinically unaffected skin: an opportunity for early detection of systemic sclerosis. In: EULAR 2020 - Annual European Congress of Rheumatology, 03-06 Jun 2020, Virtual.
Proceedings Paper
Wasson, C., Clavane, E., Ross, R. et al. (7 more authors) (2023) OP0113 The Beta Secretase Bace1 Drives Systemic Sclerosis Fibroblasts Activation Through Β-Catenin And Notch Signalling. In: Annals of the Rheumatic Diseases (ARD). EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , p. 75.
Del Galdo, F. orcid.org/0000-0002-8528-2283, Lescoat, A., Conaghan, P.G. et al. (24 more authors) (2023) OP0234 2023 Update Of Eular Recommendations For The Treatment Of Systemic Sclerosis. In: Annals of the Rheumatic Diseases (ARD). EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 154-155.
Bruni, C., Tofani, L., Fretheim, H. et al. (55 more authors) (2023) OP0238 Immunosuppression With Targeted Dmards Reduces Morbidity And Mortality In Pre-Capillary Pulmonary Hypertension Associated With Systemic Sclerosis: A Eustar Analysis. In: Annals of the Rheumatic Diseases (ARD). EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 157-159.
Klotsche, J., Foeldvari, I., Torok, K. et al. (37 more authors) (2023) POS0141 Application Of Criss Score, Revised Criss Score And RCID Score In Patients With Juvenile Systemic Sclerosis. In: Annals of the Rheumatic Diseases (ARD). EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 290-291.
Del Galdo, F. orcid.org/0000-0002-8528-2283, Bissell, L.A., Huang, S. et al. (4 more authors) (2023) POS0338 Development And Validation Of Ranked Composite Important Difference (RCID) Score In Diffuse Cutaneous Systemic Sclerosis. In: Annals of the Rheumatic Diseases (ARD). EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , p. 416.
Cheung, W.C., Shukla, R., Dumitru, R. et al. (8 more authors) (2023) POS0627 Blood-Based Protein Biomarkers Are Associated With Subclinical Cardiovascular Abnormalities As Defined By Cardiovascular Magnetic Resonance Imaging In Systemic Sclerosis (Ssc) Patients. In: Annals of the Rheumatic Diseases (ARD). EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 587-588.
De Lorenzis, E., Mor, A., Ross, R. et al. (5 more authors) (2023) CCL24 serum concentration predicts both vascular and fibrotic complications in systemic sclerosis. In: Annals of the Rheumatic Diseases. EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , p. 971.
Hughes, M., Di Donato, S., Gjeloshi, K. et al. (9 more authors) (2023) MRI digital artery volume index (DAVIX©) as quantitative, continuous imaging outcome measure of vascular disease in systemic sclerosis. In: Annals of the Rheumatic Diseases. EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , p. 1018.
Lescoat, A., Chen, Y., Murphy, S.L. et al. (22 more authors) (2023) POS1258 Results from a nominal group technique exercise for the creation of a combined response index for limited cutaneous systemic sclerosis: The CRISTAL project. In: Annals of the Rheumatic Diseases. EULAR 2023 - European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 971-972.
Hensor, E., Lazzaroni, M.G., Wilson, M. et al. (2 more authors) (2023) Pitfalls when estimating causal effects in observational data: a simulation study based on the eustar database. In: Annals of the Rheumatic Diseases. EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 991-992.
Lescoat, A., Bertoldo, E., Colic, J. et al. (6 more authors) (2023) Systematic literature review for the 2023 update of eular recommendations for the treatment of systemic sclerosis. In: Annals of the Rheumatic Diseases. EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , p. 973.
Teenan, O., Kenaan, A., Del Galdo, F. orcid.org/0000-0002-8528-2283 et al. (2 more authors) (2023) 1577 MicroRNA biomarkers in interstitial skin fluid for preclinical diagnosis of scleroderma. In: Journal of Investigative Dermatology. 1st International Societies for Investigative Dermatology Meeting (ISID 2023), 10-13 May 2023, Tokyo, Japan. Elsevier , S270.
De Lorenzis, E., Kakkar, V., Di Donato, S. et al. (4 more authors) (2023) P159 Clinical trajectories and predictors of hand function deterioration in systemic sclerosis. In: Rheumatology. British Society for Rheumatology Annual Conference 2023, 24-26 Apr 2023, Manchester, UK. Oxford University Press .
Ross, R.L., Clarke, E., Merchant, W. et al. (8 more authors) (2023) P162 Biosamples from VEDOSS patients show classic pathological signs of Scleroderma: Opportunity for a biological diagnosis of disease. In: Rheumatology. British Society for Rheumatology Annual Conference 2023, 2023-04-24 2023-04-26, Manchester, UK. Oxford University Press .
Bryon, J.A., Wasson, C., Ross, R.L. et al. (2 more authors) (2023) Systemic Sclerosis Dermal Fibroblast-derived Exosomes trigger a Type I Interferon Response in Keratinocytes, through Tank Binding Kinase 1. In: Rheumatology. British Society for Rheumatology Annual Conference 2023, 24-26 Apr 2023, Manchester, UK. Oxford University Press .
Lazzaroni, M.G., Wilson, M., Hensor, E. orcid.org/0000-0002-5245-4755 et al. (15 more authors) (2022) POS0893 Factors to consider for measuring the effect of lung function on patient reported outcomes in Systemic Sclerosis patients: Analysis of the EUSTAR database. In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , pp. 743-744.
De Lorenzis, E., Kakkar, V., Ross, R. et al. (11 more authors) (2022) POS0876 Serum Interferon Score Predicts Severity Of Patient Reported Hand Disability In Systemic Sclerosis. In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , pp. 733-734.
Dumitru, R.B., Goodall, A., Broadbent, D. et al. (6 more authors) (2020) FRI0236 First pilot study of T1 mapping MRI with ECV measurement of peripheral muscle in systemic sclerosis patients shows diffuse fibrosis. In: Annals of the Rheumatic Diseases. EULAR 2020 - European E-Congress of Rheumatology, 03-06 Jun 2020, Online. BMJ , p. 702.
Wasson, C.W., Abignano, G. orcid.org/0000-0002-1479-0133, Ross, R. et al. (1 more author) (2020) O30 Long non-coding RNA HOTAIR induces beta catenin expression in systemic sclerosis through EZH2 dependent repression of Axin-2. In: Rheumatology. British Society for Rheumatology Annual Conference 2020, 20-22 Apr 2020, Glasgow, UK. Oxford University Press , ii14.
Karadag, D.T., Lettieri, G., Picerno, V. et al. (7 more authors) (2020) P162 Cross-validation and complementary value of optical coherence tomography and high frequency ultrasound for the assessment of skin disease in systemic sclerosis. In: Rheumatology. British Society for Rheumatology Annual Conference 2020, 20-22 Apr 2020, Glasgow, UK. Oxford University Press , ii78.
Ross, R.L., Georgiou, I., Carriero, A. et al. (6 more authors) (2020) P163 Biosamples from at risk SSc patients show classic pathological signs of scleroderma: opportunity for a diagnosis of pre-clinical SSc. In: Rheumatology. British Society for Rheumatology Annual Conference 2020, 20-22 Apr 2020, Glasgow, UK. Oxford University Press .